Caco-2 cell permeability assays to measure drug absorption
暂无分享,去创建一个
[1] D. Ritchie,et al. The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery. , 2001, Current topics in medicinal chemistry.
[2] Shiyin Yee,et al. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.
[3] K. Audus,et al. The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies , 1990, Pharmaceutical Research.
[4] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.
[5] P. Artursson,et al. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.
[6] K Gubernator,et al. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.
[7] W. Niessen,et al. Progress in liquid chromatography-mass spectrometry instrumentation and its impact on high-throughput screening. , 2003, Journal of chromatography. A.
[8] J. Pezzuto,et al. Human, Rat, and Mouse Metabolism of Resveratrol , 2002, Pharmaceutical Research.
[9] S. Stavchansky,et al. Quantitative determination of saquinavir from Caco-2 cell monolayers by HPLC-UV. High performance liquid chromatography. , 2003, Biomedical chromatography : BMC.
[10] S. Bhattacharyya. Combinatorial approaches in anticancer drug discovery: recent advances in design and synthesis. , 2001, Current medicinal chemistry.
[11] J. Pang,et al. Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry. , 2000, Journal of mass spectrometry : JMS.
[12] D. Shen,et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. , 1997, The Journal of pharmacology and experimental therapeutics.
[13] T. Walle,et al. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. , 1999, Biochemical pharmacology.
[14] B. Aungst,et al. The Influence of Donor and Reservoir Additives on Caco-2 Permeability and Secretory Transport of HIV Protease Inhibitors and Other Lipophilic Compounds , 2000, Pharmaceutical Research.
[15] R. Micetich,et al. High-throughput caco-2 cell permeability screening by cassette dosing and sample pooling approaches using direct injection/on-line guard cartridge extraction/tandem mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.
[16] P. Augustijns,et al. Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures. , 1999, International journal of pharmaceutics.
[17] Y. Berger,et al. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications , 1995, Cell Biology and Toxicology.
[18] S. Nylander,et al. Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans , 1997, Pharmaceutical Research.
[19] J. Pappenheimer,et al. Structural basis for physiological regulation of paracellular pathways in intestinal epithelia , 2005, The Journal of Membrane Biology.
[20] M. A. Moseley,et al. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[21] V. Lee. Membrane transporters. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[22] W. Kramer,et al. Interaction of renin inhibitors with the intestinal uptake system for oligopeptides and beta-lactam antibiotics. , 1990, Biochimica et biophysica acta.
[23] I. Hidalgo,et al. Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco-2 cells. , 1991, Life sciences.
[24] M. Yazdanian,et al. Evaluation of an accelerated Caco-2 cell permeability model. , 2000, Journal of pharmaceutical sciences.
[25] P. Langguth,et al. Compound mixtures in Caco-2 cell permeability screens as a means to increase screening capacity. , 2001, Die Pharmazie.
[26] G. Amidon,et al. Utilization of peptide carrier system to improve intestinal absorption: targeting prolidase as a prodrug-converting enzyme. , 1992, Journal of pharmaceutical sciences.
[27] H H USSING,et al. Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.
[28] Kristina Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .
[29] J. Kolars,et al. CYP3A gene expression in human gut epithelium. , 1994, Pharmacogenetics.
[30] I. Hidalgo,et al. Assessing the absorption of new pharmaceuticals. , 2001, Current topics in medicinal chemistry.
[31] Claude Roques,et al. Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line , 1998, Pharmaceutical Research.
[32] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[33] S. Yamashita,et al. Investigations of influx and accumulation processes of beta-lactam antibiotics and their role in the transmural transfer across rat jejunum. , 1986, Journal of pharmacobio-dynamics.
[34] P. Artursson,et al. Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.
[35] Huimin Lin,et al. Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture Model , 2003, Journal of Pharmacology and Experimental Therapeutics.
[36] J. Robinson,et al. Transport of human growth hormone across Caco-2 cells with novel delivery agents: evidence for P-glycoprotein involvement. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[37] R. Mckinnon,et al. Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. , 1995, Gut.
[38] R A Morrison,et al. Current methodologies used for evaluation of intestinal permeability and absorption. , 2000, Journal of pharmacological and toxicological methods.
[39] P. Watkins,et al. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. , 1987, The Journal of clinical investigation.
[40] Akira Tsuji,et al. Carrier-Mediated Intestinal Transport of Drugs , 1996, Pharmaceutical Research.
[41] R. Borchardt,et al. Metabolism of L-alpha-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo. , 1994, Drug metabolism and disposition: the biological fate of chemicals.
[42] C E Hop,et al. Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery. , 1999, Rapid communications in mass spectrometry : RCM.
[43] H. Ussing,et al. Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. Reprinted from Acta. Physiol. Scand. 23: 110-127, 1951. , 1999, Journal of the American Society of Nephrology : JASN.
[44] Young Geun Shin,et al. Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. , 2003, Combinatorial chemistry & high throughput screening.
[45] D K Yu,et al. The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions , 1999, Journal of clinical pharmacology.
[46] M. Humphrey,et al. Peptides and related drugs: a review of their absorption, metabolism, and excretion. , 1986, Drug metabolism reviews.
[47] W. Peters,et al. Cytochromes P-450 in the intestinal mucosa of man. , 1989, Biochemical pharmacology.
[48] Risto Kostiainen,et al. N-in-One Permeability Studies of Heterogeneous Sets of Compounds Across Caco-2 Cell Monolayers , 2003, Pharmaceutical Research.
[49] P. Watkins,et al. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. , 1997, Molecular pharmacology.
[50] M. Rousset,et al. Intestinal responses to xenobiotics. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.
[51] P. Artursson,et al. Transport and permeability properties of human Caco-2 cells: An in vitro model of the intestinal epithelial cell barrier , 1990 .
[52] T. Walle,et al. Transport and Metabolism of the Tea Flavonoid (–)-Epicatechin by the Human Intestinal Cell Line Caco-2 , 2001, Pharmaceutical Research.
[53] S. L. Clark. The Ingestion of Proteins and Colloidal Materials by Columnar Absorptive Cells of the Small Intestine in Suckling Rats and Mice , 1959, The Journal of biophysical and biochemical cytology.
[54] P. Watkins,et al. First-pass midazolam metabolism catalyzed by 1alpha,25-dihydroxy vitamin D3-modified Caco-2 cell monolayers. , 1999, The Journal of pharmacology and experimental therapeutics.
[55] J. Hochman,et al. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[56] R. Conradi,et al. Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa , 1990, Pharmaceutical Research.
[57] T. Tsuruo,et al. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. , 1993, The Journal of biological chemistry.
[58] R. Morrison,et al. Higher-throughput screening for Caco-2 permeability utilizing a multiple sprayer liquid chromatography/tandem mass spectrometry system. , 2003, Rapid communications in mass spectrometry : RCM.
[59] Edward B. Roche,et al. Design of biopharmaceutical properties through prodrugs and analogs , 1977 .
[60] Thomas J. Raub,et al. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.
[61] L. Romanyshyn,et al. Bioanalytical applications of 'fast chromatography' to high-throughput liquid chromatography/tandem mass spectrometric quantitation. , 2000, Rapid communications in mass spectrometry : RCM.
[62] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[63] H Lennernäs,et al. Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.
[64] P. Galletti,et al. Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco‐2 cells , 2000, FEBS letters.
[65] P. Beaune,et al. Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. , 1990, The Journal of pharmacology and experimental therapeutics.
[66] Richard A. Morrison,et al. Evaluation of Biocoat® Intestinal Epithelium Differentiation Environment (3-Day Cultured Caco-2 Cells) as an Absorption Screening Model with Improved Productivity , 1997, Pharmaceutical Research.
[67] G. Caldwell,et al. In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry. , 1998, Journal of mass spectrometry : JMS.
[68] M Rowland,et al. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. , 2001, The Journal of pharmacology and experimental therapeutics.
[69] G Mannens,et al. Strategies for absorption screening in drug discovery and development. , 2001, Current topics in medicinal chemistry.
[70] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.